1) Fosinopril sodium
福辛普利钠
1.
In this paper,application on determination of residual solvent in medicine by wide-bore capillary HS-GC are mainly introduced,the test methods for Heparin Sodium,Xantinol Nicotinate,Fosinopril Sodium and Cefozopran Hydrochloride are established,through establishing those test method,the principl.
本文通过建立原料药肝素钠、烟酸占替诺、福辛普利钠和盐酸头孢唑兰中残留溶剂分析测定方法,阐述了顶空进样一大口径毛细管气相色谱法检测药物中残留溶剂的应用,通过研究建立方法,探讨了顶空进样大口径毛细管气相色谱法应用开发和实际应用问题。
2.
The synthesis methods of fosinopril sodium and key intermediate(trans)-4-cyclohexyl-L-proline had been reviewed.
福辛普利钠是一种含次膦酸酯基的第三代血管紧张素转换酶抑制剂。
2) fosinopril
福辛普利
1.
Relationship of polymorphism of angiotensin converting enzyme gene and the effect of Fosinopril;
ACE基因多态性与福辛普利降压疗效的关系
2.
Resarch on the Intervention of Fosinopril on the Formation of Atherosclerosis;
福辛普利对兔动脉粥样硬化形成的干预作用观察
3.
Simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma by LC-MS/MS;
LC-MS/MS法测定人血浆中福辛普利及其活性代谢物福辛普利拉
3) Monopril
福辛普利
1.
Effect of Monopril on Exprersion of Transforming Grouth Factor-β_1(TGF-β_1) mRNA in Diabetic Kidney;
福辛普利对糖尿病大鼠肾皮质TGF-β_1 mRNA表达的影响及意义
2.
The Study of Simvastatin and Monopril Treatment Hypertension;
辛伐他汀联合福辛普利治疗原发性高血压
3.
Combination therapy with Losartan and Monopril to halt progression of diabetic nephropathy;
氯沙坦和福辛普利联合治疗糖尿病肾病的疗效观察
4) Fosinpril
福辛普利
1.
The protective effect of Fosinpril on kidney in elderly patients with hypertention;
福辛普利对老年高血压患者肾保护作用的临床研究
2.
Methods One hundred fourty two patients that remal hypertension were diagnosed were randomly allocated into two groups to be treated for 8 weeks:felodipine treated group(83 cases)and Fosinpril divided group(59 cases).
方法将142例确诊为肾性高血压的患者随机分为非洛地平治疗组(83例)和福辛普利对照组(59例)两组,共治疗8周,检测血压、肾功能、尿蛋白、心率、服药情况及副反应发生情况等。
3.
Objective To evaluate the effects of Fosinpril and captopril on microalbuminuria (UAE) and glomerular filtration rate (GFR) in elderly patients.
73m- 2 之间 ,按序数分成均等二组 :福辛普利组、卡托普利组 ,分别进行治疗前后、二组之间降压幅度、UAE、GFR的比较。
5) Sodium Fosinopril
福辛普列钠
6) fosinoprilat
福辛普利拉
1.
Simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma by LC-MS/MS;
LC-MS/MS法测定人血浆中福辛普利及其活性代谢物福辛普利拉
2.
The Protective Effect of Fosinoprilat on Cultured Cardiocytesin Anoxia/Reoxygenation Injury;
福辛普利拉对培养乳鼠心肌细胞缺氧/复氧损伤的保护作用
3.
The Protective Effect of Fosinoprilat on Culture Cardiocytes in Anoxia/Reoxygenation Injury and Ca~(2+) Pump Pactivity;
福辛普利拉对培养乳鼠心肌细胞缺氧/复氧损伤的保护作用及其与钙泵的关系
补充资料:福辛普利钠
分子式:C30H45NNaO7P
分子量:585.65
CAS号:88889-14-9
性质:
分子量:585.65
CAS号:88889-14-9
性质:
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条